维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="LALWANI GA"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	An optical coher-ence tomography-guided,variable dosing regimen with intravitre-al ranibizumab(Lucentis) for neovascular age-related macular de-generation 显示文摘	Fung AE Lalwani GA Roseufeld PJ	2007	Am J Ophthalmol2007，143，4：	1
2	A variable-dosing regimen with intravitreal ranibizumab for neovascular age-relat- ed macular degeneration:year 2 of the PRONTO Study显示文摘	Lalwani GA Rosenfeld PJ Fung AE	2009	Am J Ophthalmol2009，148，1：	1
3	A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PRONTO Study 显示文摘	Lalwani GA Rosenfeld PJ Fung AE	2009	Am J Ophthalmol2009，148，1：	1
4	Off-label use of intravitreal bevacizumab(Avastin)for salvage treatment in progressive threshold retinopathy of prematurity显示文摘	Lalwani GA Berrocal AM Murray TG	2008	Retina2008，28，：	1
5	Ranibizumab: Phase clinical trial results 显示文摘	Rosenfeld P J Rich RM Lalwani GA	2005	Ophthalmol Clin North Am2005，19，3：	1
6	Off-label use of in- truvitreal bevaeizumah (Avastin)for salvage treatment in progres- sive threshold retinopathy of prematurity显示文摘	Lalwani GA Berroeal AM Murray TG	2008	Retina2008，28，3：	1
7	Off-label use of intravitreal bevacizumab (Avastin)for salvage treatment in progressive threshold retinopathy of prematurity显示文摘	Lalwani GA Berrocal AM Murray TG	2008	Retina2008，28，3：	1
8	Ranibizumab:Phase Ⅲ clinical trial results显示文摘	Rosenfeld PJ Rich RM Lalwani GA	2006	Ophthalmol Clin North Am2006，19，3：	1
9	An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age- related macular degeneration显示文摘	Fung AE Lalwani GA Rosenfeld PJ	2007	Am J Ophthalmol2007，143，4：	1
10	An optical coherence tomography-guided,variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration显示文摘	Fung AE Lalwani GA Rosenfeld PJ Dubovy SR Michels S Feuer WJ	2007	Am J Ophthalmol2007，143，：	1
11	Off-label use of intravitrea 1 bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prema- turity 显示文摘	Lalwani GA Berrocal AM Murray TG Buch M Cardone S Hess D et ol	2008	Retina2008，28，3：	1
12	Ranibizumab:Phase clinical trial Results显示文摘	Rosenfeld PJ Rich RM Lalwani GA	2006	Ophthalmol Clin North Am2006，19，3：	1
13	An optical coherence tomography -guided variable dosing regimen with intravitreal ranibizumabf Lucentis Ifor neovascular age-related macular degeneration显示文摘	Fung AE Lalwani GA Roseufeld PJ	2007	Am J Ophthalmol2007，143，：	1
14	An optical coherence tomo- graphy-guided variable dosing regimen with intravitreal ranibizumab(Lucentis) for neovascuhr age-related macular degeneration 显示文摘	FUNG AE LALWANI GA ROSEUFELD P J DUBOVY SR MICHELS S FEUER WJ	2007	Am J Ophthalmol2007，143，4：	1
15	Ranibizumab: Phase III clinical trial resuhs显示文摘	Rosenfeld PJ Rich RM Lalwani GA	2006	Ophthamlol Clin North Am2006，19，3：	1
16	Ranibizumab:Phase Ⅲ clinical trial results显示文摘	Rosenfeld PJ Rich RM Lalwani GA	2006	Ophthalmol Clin North Am2006，19，：	1
17	Ranibizumab: Phase Ⅲ clinical trial results 显示文摘	ROSENFELD PJ RICH RM LALWANI GA	2006	Ophthalmol Clin North Am2006，19，3：	1
18	An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration 显示文摘	FUNG AE LALWANI GA ROSENFELD PJ	2007	Am J Ophthalmol2007，143，4：	1
19	An opticalcoher- ence tomography-guided variable dosing regimen withintravit- real Ranibizumab(Lucentis)for neovascular age-relatedmacu- lar degeneration显示文摘	Fung AE Lalwani GA Roseufeld PJ	2007	Am J Ophthalmol2007，143，4：	1
20	Ranibizumab: phase m clinical trial results显示文摘	Roseufeld PJ Rich RM Lalwani GA	2006	0phthalmol Clin North Am2006，19，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示